Obesity: Appetite drug could mark 'new era' in tackling condition – BBC News

Posted on

A drug that suppresses urge for food has led to some people shedding higher than a fifth of their physique weight, a critical worldwide trial reveals.

A weekly injection of the drug, semaglutide, was given alongside advice on food plan and health.

The look at, carried out on just about 2,000 people, confirmed a imply 15kg weight discount all through the 15-month trial.

Scientists said the outcomes may mark a “new period” in treating weight issues with way more therapies on the horizon.

Jan, from Kent, misplaced 28kg (4 stone), equal to higher than a fifth of her physique weight.

“The drug modified my life and fully altered my strategy to meals,” she said.

She said weight-reduction plan had made her “depressing” nonetheless taking the drug was totally fully completely different as she was a lot much less hungry.


Nevertheless, now Jan has come off the trial her urge for food has returned and she or he is inserting weight once more on.

She said: “It felt easy losing a few pounds whereas on the trial, however now it has gone again to feeling like a relentless battle with meals.”

Semaglutide will already be acquainted to some people who use it as a treatment for type 2 diabetes, nonetheless this trial checked out giving it at higher doses.

  • Tesco urged by patrons to advertise additional healthful meals

The drug works by hijacking the physique’s urge for food ranges and mimicking a hormone – often known as GLP1 – that is launched after consuming a filling meal.

The trial gave some people the drug and others a dummy injection, whereas every groups obtained the life-style advice.

The outcomes, revealed inside the New England Journal of Medication, confirmed people misplaced a imply of 15kg on semaglutide in distinction with 2.6kg with out.

Nevertheless, 32% of people misplaced a fifth of their physique weight with the drug, in distinction with fewer than 2% on the dummy treatment.

‘New interval’

Prof Rachel Batterham, from UCL and one among many UK researchers, knowledgeable the BBC Information website: “This can be a game-changer within the quantity of weight reduction it causes.

“I’ve spent the ultimate 20 years doing weight issues evaluation, up until now we have now not had an environment friendly treatment for weight issues apart from bariatric surgical process.”

She stated losing a few pounds would scale back the chance of coronary heart illness, diabetes and of extreme Covid-19.

Semaglutide is being submitted to medicine regulators so can’t be routinely prescribed. Nevertheless, Prof Batterham expects the drug can be used initially by specialist weight reduction clinics reasonably than being extensively out there.

There have been side-effects to the remedy together with nausea, diarrhoea, vomiting, and constipation. And there are five-year research happening to see if weight reduction could be sustained in the long run.

Prof Sir Stephen O’Rahilly, from the College of Cambridge, stated: “The amount of weight discount achieved is bigger than that seen with any licensed anti-obesity drug.

“That is the beginning of a brand new period for weight problems drug improvement with the long run path being to realize ranges of weight reduction similar to semaglutide, whereas having fewer side-effects.”

Dr Duane Mellor, a dietician and from Aston Medical Faculty, said: “It’s helpful to have a possible choice to assist individuals shed some pounds, nevertheless we have to acknowledge that weight reduction will nonetheless want life-style change, and that any medicine or change in life-style can carry potential dangers and side-effects.

“So, it is always intelligent to speak to a properly being expert sooner than trying to shed some kilos.”

Observe James on Twitter

Let’s block commercials! (Why?)

Leave a Reply

Your email address will not be published. Required fields are marked *